NCT01466686: A reported trial by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT01466686 |
|---|---|
| Title | A Phase II Trial of Low Dose Fractionated Radiation Therapy as a Chemo-Potentiator of Salvage Temozolomide for Recurrent Anaplastic Astrocytoma and Glioblastoma Multiforme |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Sept. 30, 2012 |
| Completion date | Dec. 31, 2021 |
| Required reporting date | Dec. 31, 2024, midnight |
| Actual reporting date | May 9, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |